ArticleFrontiers in public health2022
The first 2 years of COVID-19 in Italy: Incidence, lethality, and health policies.
Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 21 citations in OpenAlex.
- The role of receptor binding and immunity in SARS-CoV-2 fitness landscape: A modeling study.iScience · 2026Article
- Impaired Generation of High-Affinity Memory B Cells and Neutralizing Antibodies Against SARS-CoV-2 in Adolescents and Young Adults With Juvenile Idiopathic Arthritis Treated With Tumor Necrosis Factor Inhibitors.ACR open rheumatology · 2026Article
- The Italian public health response during the pandemic emergency: from qualitative data to the "performance index" of care provided by Spoleto Hospital.Frontiers in public health · 2025Article
- Exposure to obinutuzumab does not affect outcomes of SARS-CoV-2 infection in vaccinated patients with newly diagnosed advanced-stage follicular lymphoma.British journal of haematology · 2024Article
- The First Two Years of COVID-19 Hospitalization Characteristics and Costs: Results from the National Discharge Registry.Healthcare (Basel, Switzerland) · 2024Article
- Surfing the Waves of SARS-CoV-2: Analysis of Viral Genome Variants Using an NGS Survey in Verona, Italy.Microorganisms · 2024Article
- Older adults' experiences of wellbeing during the COVID-19 pandemic: a comparative qualitative study in Italy and Switzerland.Frontiers in sociology · 2024Article
- Persistence of circulating CD169+monocytes and HLA-DR downregulation underline the immune response impairment in PASC individuals: the potential contribution of different COVID-19 pandemic waves.Current research in microbial sciences · 2024Article
- Estimating SARS-CoV-2 infections and associated changes in COVID-19 severity and fatality.Influenza and other respiratory viruses · 2023Article
- Post-COVID Symptoms in Occupational Cohorts: Effects on Health and Work Ability.International journal of environmental research and public health · 2023Article
- Which variables and determinants influence online food delivery consumption among workers and students? Results from the DELIvery Choice In OUr Society (DELICIOUS) cross-sectional study.Frontiers in public health · 2023Article
- Loneliness during the COVID-19 Pandemic in Patients with Burning Mouth Syndrome: A Multicentric Case-Control Italian Study.Depression and anxiety · 2023Article
- Measuring the impact of the COVID-19 epidemic on university resumption and suggestions for countermeasures.Frontiers in public health · 2022Review
- Two-year follow-up of the COVID-19 pandemic in Mexico.Frontiers in public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The novel coronavirus disease 2019 (COVID-19) is an ongoing pandemic that was first recognized in China in December 2019. This paper aims to provide a detailed overview of the first 2 years of the pandemic in Italy. Design and methods: Using the negative binomial distribution, the daily incidence of infections was estimated through the virus's lethality and the moving-averaged deaths. The lethality of the original strain (estimated through national sero-surveys) was adjusted daily for age of infections, hazard ratios of virus variants, and the cumulative distribution of vaccinated individuals. Results: From February 24, 2020, to February 28, 2022, there were 20,833,018 (20,728,924-20,937,375) cases distributed over five waves. The overall lethality rate was 0.73%, but daily it ranged from 2.78% (in the first wave) to 0.15% (in the last wave). The first two waves had the highest number of daily deaths (about 710) and the last wave showed the highest peak of daily infections (220,487). Restriction measures of population mobility strongly slowed the viral spread. During the 2nd year of the pandemic, vaccines prevented 10,000,000 infections and 115,000 deaths. Conclusion: Almost 40% of COVID-19 infections have gone undetected and they were mostly concentrated in the first year of the pandemic. From the second year, a massive test campaign made it possible to detect more asymptomatic cases, especially among the youngest. Mobility restriction measures were an effective suppression strategy while distance learning and smart working were effective mitigation strategies. Despite the variants of concern, vaccines strongly reduced the pandemic impact on the healthcare system avoiding strong restriction measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.